The company expects the restructuring plan to be substantially complete during the first half of fiscal year 2025 and expects the discontinuation of the patch pump program and organizational ...

Analysts called a stock sell-off at Embecta "unwarranted" and believe the company is moving in the right direction despite recent challenges.

Traditionally they have involved a canula and separate connected pump, but more recent models have taken the form of a patch with a pump mounted directly upon it. When [Pete Schwamb]’s daughter ...

The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was cleared by the Food and ...

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple breaches” of their ...